SCHEMBL3972281

SCHEMBL3972281

CCNCCN(CC)CCNCC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
GLA P06280 1/20 0.43
CYP1A2 P05177 1/20 0.41
TSHR P16473 1/20 0.41
TP53 P04637 1/20 0.39
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KDM1A O60341 5/20 0.35
PAOX Q6QHF9 1/20 0.32
SAT1 P21673 2/20 0.32
GAA P10253 1/20 0.31
CYP2C9 P11712 1/20 0.31
USP2 O75604 1/20 0.31
HTT P42858 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
CYP3A4 P08684 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9079152 0.97 CYP2C19 (0.41) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL4192702 0.95 CYP2C19 (0.39) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL250410 0.94 CYP2C19 (0.43) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL23975243 0.92 TSHR (0.42) CYP2C19MEN1KMT2AGLACYP1A2
Ammonia Solution, Strong SCHEMBL11798888 0.92 CYP2C19 (0.41) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL8803099 0.92 CYP2C19 (0.41) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL12069860 0.90 PRMT3 (0.40) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL8343447 0.89 CYP2C19 (0.46) CYP2C19MEN1KMT2AGLACYP1A2
Hydrochloric Acid SCHEMBL8316323 0.89 CYP2C19 (0.39) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL1543425 0.88 CYP2C19 (0.38) CYP2C19MEN1KMT2AGLACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673963-B2 Process for preparing sorbic acid by thermal cleavage NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) 2004-01-06 US claimed
US-20030060658-A1 Process for preparing sorbic acid by thermal cleavage NUTRINOVA NUTRITION SPECIALTIES & FOOD INGREDIENTS GMBH (DE) 2003-03-27 US claimed
EP-1295860-A2 Process for the preparation of sorbic acid by thermal decomposition Nutrinova Nutrition Specialties & Food Ingredients GmbH (DE) 2003-03-26 EP claimed
US-20230118462-A1 Process for Making Sorbic Acid from Renewable Materials NUTRINOVA NETHERLANDS B.V. (NL) 2023-04-20 US disclosed
CN-110423653-B Dipping powder for tableware 深圳市耀星实业有限公司 2021-03-26 CN disclosed
US-7514478-B2 Solid, radiation-curing binders with reactive thinners BAYER MATERIALSCIENCE AG (DE) 2009-04-07 US disclosed
EP-1538186-B1 Solid binding agents hardened by means of radiation containing reactive diluents BAYER MATERIALSCIENCE AG (DE) 2007-09-05 EP disclosed
US-20050170185-A1 Solid, radiation-curing binders with reactive thinners ALLNEX NETHERLANDS B.V. (NL) 2005-08-04 US disclosed
EP-1538186-A1 Solid binding agents hardened by means of radiation containing reactive diluents Bayer MaterialScience AG (DE) 2005-06-08 EP disclosed
US-20050064468-A1 concentration, removing or separation of nucleotide bases or nucleotide sequences containing bases from solid supports IBC ADVANCED TECHNOLOGIES, INC. 2005-03-24 US disclosed
EP-1453602-A4 COMPOSITIONS AND METHODS FOR SEPARATING HETEROCYCLIC AROMATIC AMINE BASES, NUCLEOSIDES, NUCLEOTIDES, AND NUCLEOTIDE SEQUENCES IBC ADVANCED TECH INC (US) 2005-01-12 EP disclosed
EP-0691328-B1 Process for producing 1,3-dialkyl-2-imidazolidinone MITSUI TOATSU CHEMICALS (JP) 1998-04-29 EP disclosed
US-5594149-A Process for producing 1,3-dialkyl-2-imidazolidinone MITSUI TOATSU CHEMICALS, INC. (JP) 1997-01-14 US disclosed
US-5583256-A Process for producing 1,3-dialkyl-2-imidazolidinone MITSUI TOATSU CHEMICALS, INC. (JP) 1996-12-10 US disclosed
EP-0691328-A1 Process for procucing 1,3-dialkyl-2-imidazolidinone MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-01-10 EP disclosed
US-4880576-A HALOGENATION OF ACIDS, FORMAMIDE CATALYSTS BAYER AKTIENGESELLSCHAFT (DE) 1989-11-14 US disclosed
EP-0137053-B1 PROCESS FOR CLEANING METAL SURFACES PHILLIPS PETROLEUM COMPANY (US) 1987-03-04 EP disclosed
EP-0137053-A1 Process for cleaning metal surfaces PHILLIPS PETROLEUM COMPANY (US) 1985-04-17 EP disclosed
EP-0050779-B1 N-ALKYLATED FORMAMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE BAYER AG (DE) 1984-05-16 EP disclosed
US-4431457-A POLYAMINES AS CLEANING COMPOUNDS PHILLIPS PETROLEUM COMPANY (US) 1984-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230118462-A1 Process for Making Sorbic Acid from Renewable Materials BCKDK, ALKBH3, MCCC2 CYP2C19 1123/4885MEN1 2653/4885KMT2A 1610/4885
US-20050064468-A1 concentration, removing or separation of nucleotide bases or nucleotide sequences containing bases from solid supports NUDT1, PCNA, NSUN2 CYP2C19 4133/4885MEN1 2474/4885KMT2A 571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.